OMIC · Categories · Form 4

OMIC - SEC Form 4 insider transactions

Singular Genomics Systems Inc. (OMIC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OMIC

• 461d
  Large owner Tang Kevin returned 372,000 shares to the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  Chief Executive Officer Spaventa Andrew returned 143,310 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  Chief Financial Officer Meeter Dalen returned 9,502 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  Chief Scientific Officer Glezer Eli N. returned 155,583 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  Chief Operating Officer Ghai Jyotsna returned 3,283 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  SEC Form 4 filed by Director Ryan Jason

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  Director Pellini Michael J returned 351,222 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  SEC Form 4 filed by Director Mardis Elaine R

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  Director Kamdar Kim P. returned 3,793,985 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  SEC Form 4 filed by Director Eisenberg Marcia

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 463d
  Director Barker David L returned 1,060,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 474d
  Chief Executive Officer Spaventa Andrew converted options into 1,907 shares, sold $15,912 worth of shares (800 units at $19.89), gifted 1,107 shares and received a gift of 1,107 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 477d
  Chief Financial Officer Meeter Dalen converted options into 500 shares, increasing direct ownership by 6% to 9,502 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 477d
  Chief Scientific Officer Glezer Eli N. converted options into 500 shares, increasing direct ownership by 0.32% to 155,583 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 477d
  Chief Operating Officer Ghai Jyotsna converted options into 250 shares, increasing direct ownership by 8% to 3,283 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 513d
  Chief Operating Officer Ghai Jyotsna converted options into 417 shares, increasing direct ownership by 16% to 3,033 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 533d
  Chief Executive Officer Spaventa Andrew converted options into 486 shares, sold $3,629 worth of shares (180 units at $20.16), gifted 306 shares and received a gift of 306 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 533d
  Chief Financial Officer Meeter Dalen converted options into 209 shares, increasing direct ownership by 2% to 9,002 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 533d
  Chief Scientific Officer Glezer Eli N. converted options into 250 shares, increasing direct ownership by 0.16% to 155,083 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 567d
  Chief Executive Officer Spaventa Andrew sold $15,669 worth of shares (695 units at $22.55), gifted 1,212 shares, received a gift of 1,212 shares and converted options into 1,907 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 567d
  Chief Financial Officer Meeter Dalen converted options into 500 shares, increasing direct ownership by 6% to 8,693 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 567d
  Chief Scientific Officer Glezer Eli N. converted options into 500 shares, increasing direct ownership by 0.32% to 154,833 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 567d
  Chief Operating Officer Ghai Jyotsna converted options into 250 shares, increasing direct ownership by 11% to 2,516 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 608d
  Chief Operating Officer Ghai Jyotsna converted options into 1,666 shares, increasing direct ownership by 278% to 2,266 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 624d
  Chief Financial Officer Meeter Dalen converted options into 209 shares, increasing direct ownership by 3% to 8,193 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 624d
  Chief Scientific Officer Glezer Eli N. converted options into 250 shares, increasing direct ownership by 0.16% to 154,333 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 624d
  Chief Executive Officer Spaventa Andrew converted options into 487 shares, sold $2,167 worth of shares (175 units at $12.38), gifted 312 shares and received a gift of 312 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 658d
  Chief Executive Officer Spaventa Andrew gifted 1,225 shares, received a gift of 1,225 shares, converted options into 1,906 shares and covered exercise/tax liability with 681 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 659d
  Chief Operating Officer Ghai Jyotsna converted options into 250 shares, increasing direct ownership by 71% to 600 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 659d
  Chief Financial Officer Meeter Dalen converted options into 500 shares, increasing direct ownership by 7% to 7,984 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 659d
  Chief Scientific Officer Glezer Eli N. converted options into 500 shares, increasing direct ownership by 0.33% to 154,083 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 715d
  Chief Financial Officer Meeter Dalen converted options into 6,250 shares, increasing direct ownership by 3% to 224,523 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 715d
  Chief Scientific Officer Glezer Eli N. converted options into 7,500 shares, increasing direct ownership by 0.16% to 4,607,500 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 715d
  Chief Executive Officer Spaventa Andrew converted options into 14,584 shares, gifted 14,584 shares and received a gift of 14,584 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 733d
  SEC Form 4 filed by Eisenberg Marcia

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 733d
  SEC Form 4 filed by Mardis Elaine R

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 733d
  SEC Form 4 filed by Kamdar Kim P.

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 733d
  SEC Form 4 filed by Barker David L

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 733d
  SEC Form 4 filed by Ryan Jason

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 733d
  SEC Form 4 filed by Pellini Michael J

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 751d
  Ghai Jyotsna converted options into 7,500 shares, increasing direct ownership by 250% to 10,500 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 751d
  Meeter Dalen converted options into 15,000 shares, increasing direct ownership by 7% to 215,273 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 751d
  Glezer Eli N. converted options into 15,000 shares, increasing direct ownership by 0.33% to 4,600,000 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 751d
  Spaventa Andrew received a gift of 57,188 shares, converted options into 57,188 shares and gifted 57,188 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 806d
  Ropp Sam converted options into 4,187 shares, increasing direct ownership by 33% to 16,750 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 806d
  Meeter Dalen converted options into 6,250 shares, increasing direct ownership by 3% to 200,273 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 806d
  Glezer Eli N. converted options into 7,500 shares, increasing direct ownership by 0.16% to 4,585,000 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 806d
  Spaventa Andrew converted options into 14,583 shares, gifted 14,583 shares and received a gift of 14,583 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 841d
  SEC Form 4 filed by Ghai Jyotsna

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 841d
  SEC Form 4 filed by Ropp Sam

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 841d
  SEC Form 4 filed by Meeter Dalen

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 841d
  SEC Form 4 filed by Glezer Eli N.

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 841d
  SEC Form 4 filed by Spaventa Andrew

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 898d
  Ropp Sam converted options into 4,188 shares, increasing direct ownership by 50% to 12,563 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 898d
  Meeter Dalen converted options into 6,250 shares, increasing direct ownership by 3% to 194,023 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 898d
  Glezer Eli N. converted options into 7,500 shares, increasing direct ownership by 0.16% to 4,577,500 units (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 898d
  Spaventa Andrew converted options into 14,583 shares, gifted 14,583 shares and received a gift of 14,583 shares (SEC Form 4)

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 992d
  SEC Form 4: Ropp Sam converted options into 4,187 shares, increasing direct ownership by 100% to 8,375 units

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 992d
  SEC Form 4: Meeter Dalen converted options into 6,250 shares, increasing direct ownership by 3% to 187,771 units

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)
• 992d
  SEC Form 4: Glezer Eli N. converted options into 7,500 shares, increasing direct ownership by 0.17% to 4,370,000 units

  4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)

Other OMIC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends